Centers for Disease Control and Prevention

Rare H5N1 Bird Flu Case in U.S. Child Sparks Public Health Investigation and Call for Vigilance

WASHINGTON, D.C. — The U.S. Centers for Disease Control and Prevention (CDC) recently confirmed the nation’s first avian influenza A(H5N1) human infection in a child, marking a significant development in ongoing …

Rare H5N1 Bird Flu Case in U.S. Child Sparks Public Health Investigation and Call for Vigilance Read More
Virpax Pharmaceuticals

Virpax Pharmaceuticals Announces Positive Results in Study for Long-Lasting Pain Relief Formulation

BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has reported encouraging results from a minipig Dose Range Finding (DRF) study for Probudur, its long-acting liposomal bupivacaine injection. Designed to provide …

Virpax Pharmaceuticals Announces Positive Results in Study for Long-Lasting Pain Relief Formulation Read More


Panavance Therapeutics

Panavance Therapeutics Unveils Promising Data on Misetionamide’s Dual Cancer Targeting Mechanism

BERWYN, PA — Panavance Therapeutics Inc. has announced groundbreaking findings this week, demonstrating the potential of their investigational drug, misetionamide (GP-2250), to tackle various forms of cancer by directly inhibiting …

Panavance Therapeutics Unveils Promising Data on Misetionamide’s Dual Cancer Targeting Mechanism Read More